Skip to main content
Premium Trial:

Request an Annual Quote

David McGee, Todd Edwards, Pierre Cassigneul


David McGee, co-founder and executive vice president of Large Scale Biology, will leave the Vaca-
ville, Calif.-based company to become a consultant in the biotechnology industry.

Todd Edwards has been appointed field technical specialist at lab automation equipment provider Protedyne. He joins the company from Lawrence Livermore National Laboratory, where he was a postdoctoral researcher, developing automated techniques for protein expression and purification. He has also worked as an assistant professor in the department of physics at Whitman College. He holds a PhD in bioengineering from the University of Washington in Seattle and a BS in physics from Haverford College.

Pierre Cassigneul has been appointed operating partner of biopharma and bio-IT consulting firm Stone Bridge Management. Cassigneul comes to the firm from Becton Dickinson, where he was vice president of diabetes management. Previously, he was senior vice president of Bayer, and general manager of the company’s diabetes self-testing business. He has also served in Ortho Diagnostic Systems’ AIDS and hepatitis business unit and at Abbott Laboratories.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.